Project Grant R41AI186683
Award Date
8/5/24
Completion Date
7/31/26
Dollars Obligated
$304K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Mountain Brook, AL 35216, USA
Similar Awards
This $881,878 federal Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to study the cross-talk between skin-resident T-cells (CD8 T resident memory cells) and keratinocytes, the primary target of herpes simplex virus (HSV) infection, to understand how this interaction influences HSV recurrence. The research will utilize advanced techniques such as single-cell RNA...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $651,832.00 to The Children's Hospital of Philadelphia Research Institute. The funding supports research to understand how the Herpes Simplex Virus (HSV) manipulates the host cell's DNA damage response and proteome to promote viral gene expression and replication. The research team will utilize global proteomic...
This $1,670,110 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of a novel, multi-compartment intravaginal ring (IVR) for the prevention of genital herpes (HSV) and unintended pregnancy. The key products and services funded under this award include: Evaluating a panel of small-molecule inhibitors of soluble adenylyl cyclase (SAC) to select a lead...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to understand, prevent, and treat infections caused by herpes simplex viruses (HSV-1 and HSV-2). The $384,363 award to Temple University will fund a 5-year study to investigate the role of the Pellino1 (PELI1) protein in regulating antiviral immunity in skin keratinocytes and the epidermis. The research aims to provide insights...
This Project Grant award for $862,440.00 was made by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports the development and evaluation of a new humanized mouse model to study gene editing therapies targeting chronic hepatitis B virus (HBV) infection. The key objectives are to: 1) Evaluate the anti-HBV efficacy of HBV gene therapy in liver-humanized NSG-PIZ mice, including assessing...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $236,292 to Tufts University School of Medicine to apply new methods to isolate and characterize the structures of herpes simplex virus (HSV) glycoprotein complexes relevant to cell entry. The award aims to obtain high-resolution structural "snapshots" of these glycoprotein complexes, which have been...
The University of Virginia received a $215,810 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, effective November 8, 2024 through October 31, 2026, will support research to identify host proteins degraded in neurons following infection by the herpes simplex virus type 1 (HSV-1) and investigate the roles of the viral proteins ICP0 and the PUL55 complex in promoting viral...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Albert Einstein College of Medicine in Bronx, NY. The $1,486,800 award, with a project period from November 7, 2024 to October 31, 2029, supports research on the role of TNFRSF14 signaling in promoting antibody-dependent cell-mediated cytotoxicity (ADCC) as a potential strategy for herpes simplex virus (HSV) vaccine development. The...
This federal Project Grant award from the National Institutes of Health (NIH), under the Trans-NIH Research Support (CFDA 93.310) program, provides $1,367,863 to Emory University to conduct biophysical research on herpesvirus capsid assembly and genome packaging. The goal is to develop new methodologies to monitor these essential viral processes in real-time, which could lead to a more complete understanding of herpesviral replication and the development of improved preventative and...